PD Dr. Dr. Imke Atreya



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cells. (2023) Ullrich K, Derdau J, Baltes C, Battistella A, Rosso G, Uderhardt S, Schulze L, et al. Journal article Increased Motility and Suppression of Ex Vivo–Expanded Regulatory T Cells Designed for Adoptive Transfer Therapy in Ulcerative Colitis (2023) Müller T, Liu L, Czerwinski T, Wiesinger M, Dedden M, Paap EM, Ullrich K, et al. Journal article How the Tumor Micromilieu Modulates the Recruitment and Activation of Colorectal Cancer-Infiltrating Lymphocytes (2022) Atreya I, Neurath M Journal article, Review article Etrolizumab-s Does Not Induce Residual Trafficking of Regulatory T Cells (2022) Schweda A, Becker E, Wiendl M, Atreya R, Atreya I, Müller T, Neurath M, Zundler S Journal article Vedolizumab blocks alpha 4 beta 7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitis (2022) Besendorf L, Müller T, Geppert CI, Schneider I, Mühl L, Atreya I, Vitali F, et al. Journal article Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets (2022) Becker E, Schweda A, Ullrich K, Voskens C, Atreya R, Müller T, Atreya I, et al. Journal article Epithelial RAC1-dependent cytoskeleton dynamics controls cell mechanics, cell shedding and barrier integrity in intestinal inflammation (2022) Martínez Sánchez LdC, Phuong Anh Ngo , Pradhan R, Becker LS, Böhringer D, Soteriou D, Kubankova M, et al. Journal article Expression and function of α4β7 integrin predict the success of vedolizumab treatment in inflammatory bowel disease (2022) Schneider I, Allner C, Mühl L, Melde M, Lissner D, Mantzivi E, Glauben R, et al. Journal article Transcriptomes of MPO-Deficient Patients with Generalized Pustular Psoriasis Reveals Expansion of CD4+ Cytotoxic T Cells and an Involvement of the Complement System (2022) Haskamp S, Frey B, Becker I, Schulz-Kuhnt A, Atreya I, Berking C, Pauli D, et al. Journal article Editorial: Loss of Epithelial Barrier Integrity in Inflammatory Diseases: Cellular Mediators and Therapeutic Targets (2021) Weidinger C, Krug SM, Voskens C, Moschen AR, Atreya I Journal article, Editorial
1 2 3 4